Patents by Inventor Roger G. Deeley

Roger G. Deeley has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Antibodies to a multidrug resistance protein
    Patent number: 6063621
    Abstract: A novel protein associated with multidrug resistance in living cells and capable of conferring multidrug resistance on a cell is disclosed. Nucleic acids encoding the novel multidrug resistance protein are also disclosed. Transformant cell lines which express the nucleic acid encoding the novel protein are also disclosed. Antibodies which bind the novel multidrug resistance protein are also disclosed. Diagnostic and treatment methods using the novel proteins, nucleic acids, antibodies and cell lines of the invention are also encompassed by the invention.
    Type: Grant
    Filed: March 20, 1995
    Date of Patent: May 16, 2000
    Assignee: Queen's University at Kingston
    Inventors: Roger G. Deeley, Susan P. C. Cole
  • Multidrug resistance proteins
    Patent number: 6025473
    Abstract: A novel protein associated with multidrug resistance in living cells and capable of conferring multidrug resistance on a cell is disclosed. Nucleic acids encoding the novel multidrug resistance protein are also disclosed. Transformant cell lines which express the nucleic acid encoding the novel protein are also disclosed. Antibodies which bind the novel multidrug resistance protein are also disclosed. Diagnostic and treatment methods using the novel proteins, nucleic acids, antibodies and cell lines of the invention are also encompassed by the invention.
    Type: Grant
    Filed: June 5, 1995
    Date of Patent: February 15, 2000
    Assignee: Queen's University at Kingston
    Inventors: Roger G. Deeley, Susan P. C. Cole
  • Methods for identifying chemosensitizers
    Patent number: 6001563
    Abstract: A novel protein associated with multidrug resistance in living cells and capable of conferring multidrug resistance on a cell is disclosed. Nucleic acids encoding the novel multidrug resistance protein are also disclosed. Transformant cell lines which express the nucleic acid encoding the novel protein are also disclosed. Antibodies which bind the novel multidrug resistance protein are also disclosed. Diagnostic and treatment methods using the novel proteins, nucleic acids, antibodies and cell lines of the invention are also encompassed by the invention.
    Type: Grant
    Filed: June 5, 1995
    Date of Patent: December 14, 1999
    Assignee: Queen's University at Kingston
    Inventors: Roger G. Deeley, Susan P.C. Cole
  • Methods for conferring multidrug resistance on a cell
    Patent number: 5891724
    Abstract: A novel protein associated with multidrug resistance in living cells and capable of conferring multidrug resistance on a cell is disclosed. Nucleic acids encoding the novel multidrug resistance protein are also disclosed. Transformant cell lines which express the nucleic acid encoding the novel protein are also disclosed. Antibodies which bind the novel multidrug resistance protein are also disclosed. Diagnostic and treatment methods using the novel proteins, nucleic acids, antibodies and cell lines of the invention are also encompassed by the invention.
    Type: Grant
    Filed: June 5, 1995
    Date of Patent: April 6, 1999
    Assignee: Queen's University at Kingston
    Inventors: Roger G. Deeley, Susan P. C. Cole
  • Methods for identifying multidrug resistant tumor cells
    Patent number: 5882875
    Abstract: A novel protein associated with multidrug resistance in living cells and capable of conferring multidrug resistance on a cell is disclosed. Nucleic acids encoding the novel multidrug resistance protein are also disclosed. Transformant cell lines which express the nucleic acid encoding the novel protein are also disclosed. Antibodies which bind the novel multidrug resistance protein are also disclosed. Diagnostic and treatment methods using the novel proteins, nucleic acids, antibodies and cell lines of the invention are also encompassed by the invention.
    Type: Grant
    Filed: June 5, 1995
    Date of Patent: March 16, 1999
    Assignee: Queen's University at Kingston
    Inventors: Roger G. Deeley, Susan P. C. Cole
  • Isolated nucleic acid molecules encoding multidrug resistance proteins
    Patent number: 5766880
    Abstract: A novel protein associated with multidrug resistance in living cells and capable of conferring multidrug resistance on a cell is disclosed. Nucleic acids encoding the novel multidrug resistance protein are also disclosed. Transformant cell lines which express the nucleic acid encoding the novel protein are also disclosed. Antibodies which bind the novel multidrug resistance protein are also disclosed. Diagnostic and treatment methods using the novel proteins, nucleic acids, antibodies and cell lines of the invention are also encompassed by the invention.
    Type: Grant
    Filed: June 5, 1995
    Date of Patent: June 16, 1998
    Assignee: Queen's University at Kingston
    Inventors: Roger G. Deeley, Susan P.C. Cole
  • Multidrug resistance protein
    Patent number: 5489519
    Abstract: A novel protein associated with multidrug resistance in living cells and capable of conferring multidrug resistance on a cell is disclosed and nucleic acids encoding the novel isoforms are disclosed. Transformant cell lines which express the nucleic acid encoding the novel protein are also disclosed. Further, diagnostic and treatment methods using the novel protein, nucleic acids and cell lines are also disclosed.
    Type: Grant
    Filed: October 26, 1993
    Date of Patent: February 6, 1996
    Assignee: Queen's University at Kingston
    Inventors: Roger G. Deeley, Susan P. C. Cole